Document is current
Any future updates will be listed below
-
Authors
Groothoff, Jaap W. https://orcid.org/0000-0002-8467-3506
Metry, Ella
Deesker, Lisa
Garrelfs, Sander
Acquaviva, Cecile
Almardini, Reham
Beck, Bodo B. https://orcid.org/0000-0003-0495-7670
Boyer, Olivia https://orcid.org/0000-0002-3957-1359
Cerkauskiene, Rimante https://orcid.org/0000-0002-1971-5044
Ferraro, Pietro Manuel https://orcid.org/0000-0002-1379-022X
Groen, Luitzen A.
Gupta, Asheeta
Knebelmann, Bertrand
Mandrile, Giorgia https://orcid.org/0000-0003-0849-2225
Moochhala, Shabbir S.
Prytula, Agnieszka
Putnik, Jovana
Rumsby, Gill https://orcid.org/0000-0002-3223-3752
Soliman, Neveen A.
Somani, Bhaskar https://orcid.org/0000-0002-6248-6478
Bacchetta, Justine https://orcid.org/0000-0002-0578-2529
- License Information
-
More Information
Article History
Accepted: 23 November 2022
First Online: 5 January 2023
Competing interests
: J.W.F. has received study grants for stable isotope and registry studies from Alnylam, Dicerna and UniQure and commissions for advisory board work and presentations for Alnylam. All these payments were made to the Research unit; no personal payments were accepted. J.W.F is also chair of the Steering Committee of OxalEurope and vice-chair of the metabolic working group of ERKNet. S.G. received study grants from Alnylam. C.A. has received consulting fees from Alnylam. B.B.B. has received consultation fees from Alnylam Pharmaceuticals and is a member of the scientific advisory board of the German PH self-support group PH Selbsthilfe e.V. O.B. has received consultancy fees and travel grants from Alnylam and Biocodex. P.M.F. has received consultant fees and grant/other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, BioHealth Italia, Gilead, Otsuka Pharmaceuticals, Rocchetta, Vifor Fresenius, and royalties as an author for UpToDate. J.B. has received consulting fees from Alnylam, Dicerna, Amgen, Bayer, Biocordex and Amolyt, and honoraria for presentations from Alnylam, Alexion, Bayer and Kyowa Kirin. J.B., B.B.B and S.S.M. are members of the Steering Committee of OxalEurope. The other authors declare no competing interests.
Free to read: This content has been made available to all.
